SI-BONE Inc (NASDAQ: SIBN) kicked off on Tuesday, up 9.33% from the previous trading day, before settling in for the closing price of $16.39. Over the past 52 weeks, SIBN has traded in a range of $11.70-$21.19.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 20.11% over the last five years. While this was happening, its average annual earnings per share was recorded 30.58%. With a float of $36.37 million, this company’s outstanding shares have now reached $41.79 million.
The firm has a total of 344 workers. Let’s measure their productivity. In terms of profitability, gross margin is 77.7%, operating margin of -26.91%, and the pretax margin is -23.82%.
SI-BONE Inc (SIBN) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of SI-BONE Inc is 13.28%, while institutional ownership is 90.62%. The most recent insider transaction that took place on Feb 03 ’25, was worth 5,562. In this transaction Director of this company sold 337 shares at a rate of $16.51, taking the stock ownership to the 17,290 shares. Before that another transaction happened on Jan 02 ’25, when Company’s President, Commercial Ops sold 3,670 for $13.90, making the entire transaction worth $51,014. This insider now owns 222,814 shares in total.
SI-BONE Inc (SIBN) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 30.58% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 26.84% during the next five years compared to 12.47% growth over the previous five years of trading.
SI-BONE Inc (NASDAQ: SIBN) Trading Performance Indicators
Take a look at SI-BONE Inc’s (SIBN) current performance indicators. Last quarter, stock had a quick ratio of 7.22. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.79.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.91, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.63 in one year’s time.
Technical Analysis of SI-BONE Inc (SIBN)
Analysing the last 5-days average volume posted by the [SI-BONE Inc, SIBN], we can find that recorded value of 0.4 million was better than the volume posted last year of 0.32 million. As of the previous 9 days, the stock’s Stochastic %D was 40.19%. Additionally, its Average True Range was 0.81.
During the past 100 days, SI-BONE Inc’s (SIBN) raw stochastic average was set at 96.21%, which indicates a significant increase from 88.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.80% in the past 14 days, which was lower than the 63.63% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.27, while its 200-day Moving Average is $14.46. Now, the first resistance to watch is $18.50. This is followed by the second major resistance level at $19.09. The third major resistance level sits at $20.25. If the price goes on to break the first support level at $16.75, it is likely to go to the next support level at $15.59. Should the price break the second support level, the third support level stands at $15.00.
SI-BONE Inc (NASDAQ: SIBN) Key Stats
The company with the Market Capitalisation of 751.54 million has total of 41,938K Shares Outstanding. Its annual sales at the moment are 138,890 K in contrast with the sum of -43,340 K annual income. Company’s last quarter sales were recorded 40,340 K and last quarter income was -6,580 K.
